Infection, vaccination and protection against melanoma - A ray of hope for novel preventive and therapeutic strategies?

European Journal of Cancer

Volumn 41, Issue 1, 2005, Pages 12-14

  Grange, J M ^a   Dore J F ^b   Coebergh, J W ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b INSERM   (France)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CANCER VACCINE; MELANOMA VACCINE;

ACUTE LEUKEMIA; ALLERGIC DISEASE; ASTHMA; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BCG VACCINATION; BESNOITIA; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER REGRESSION; DISEASE ASSOCIATION; EDITORIAL; ENVIRONMENTAL FACTOR; ERYSIPELAS; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; IMMUNOSURVEILLANCE; INDUSTRIALIZATION; LUNG TUBERCULOSIS; LYMPHOPROLIFERATIVE DISEASE; MELANOMA; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTOZOON; RETROVIRUS; SARCOMA; TH2 CELL; TOXOPLASMA GONDII; VACCINATION; X RAY MICROANALYSIS;

BCG VACCINE; CANCER VACCINES; HUMANS; INFECTION; MELANOMA; RETROVIRIDAE INFECTIONS; SKIN NEOPLASMS;

EID: 11144256550     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.09.024     Document Type: Editorial

References (24)

1. Pathological Society of London. Discussion on cancer. Lancet 1874, 1, 334-336 and 586-594
2. W.B. Coley Treatment of inoperable malignant tumour with the toxins of erysipelas and Bacillus prodigiosus Trans Am Surg Assoc 12 1894 183 196
3. S. Takeuchi A new look at the history of tumour immunotherapy - for its fruitful future through overcoming the widespread cynicism Hum Cell 9 1996 1 10 [In Japanese, with English abstract]
4. J.L. Stanford, C.A. Stanford, and J.M. Grange Environmental echoes Sci Prog 84 Part 2 2001 105 124
5. J.-F. Bach The effect of infections on susceptibility to autoimmune and allergic diseases N Engl J Med 347 2002 911 920
6. M.F. Greaves Aetiology of acute leukaemia Lancet 349 1997 344 349
7. F.D. Martinez, and P.G. Holt Role of microbial burden in aetiology of allergy and asthma Lancet 354 Suppl 2 1999 12 15
8. F. Perrillat, J. Clavel, and M.F. Auclerc Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study Br J Cancer 86 2002 1064 1069
9. X. Ma, P.A. Buffler, and S. Selvin Day-care attendance and risk of childhood acute lymphoblastic leukamia Br J Cancer 86 2002 1419 1424
10. J.M. Grange, and J.L. Stanford BCG vaccination and cancer Tubercle 71 1990 61 64
11. A. Pfahlberg, K.F. Kölmel, and J.M. Grange Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study J Invest Dermatol 119 2002 570 575
12. K.F. Kölmel, A. Pfahlberg, and G. Mastrangelo Infections and melanoma risk: results of a multicentre EORTC case-control study Melanoma Res 9 1999 511 519
13. Krone B, Kölmel KF, Grange JM, et al. Impact of vaccinations and infectious diseases on melanoma risk - evaluation of an EORTC case-control study. Eur J Cancer 2003, 39, 2372-2378
14. Kölmel KF, Grange JM, Krone B, et al. Prior immunisation with vaccinia or BCG is associated with better survival. An EORTC cohort study on 572 patients. Eur J Cancer 2005, this issue (doi: 10.1016/j.ejca.2004.09.023)
15. Krone B, Kölmel KF, Henz BM, Grange JM. Protection against melanoma by vaccination with Bacille Calmette-Guérin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control. Eur J Cancer 2005, this issue (doi: 10.1016/j.ejca.2004. 08.100)
16. E.D. Sverdlov Perpetually mobile footprints of ancient infections in human genome FEBS Lett 428 1998 1 6
17. S. Pavel, F. van Nieuwpoort, and H. van der Meulen Disturbed melanin synthesis and chronic oxidative stress in dysplastic naevi Eur J Cancer 40 2004 1423 1430
18. P. Obermayer-Straub, and M.P. Manns Hepatitis C and D, retroviruses and autoimmune manifestations J Autoimmun 16 2001 275 285
19. J.L. Stanford, C.A. Stanford, B. Baban, and J.M. Grange Therapeutic vaccination for cancer: the potential value of mycobacterial products Int J Pharmaceut Med 12 1999 191 195
20. P.E.M. Fine Variation in protection by BCG: implications of and for heterologous immunity Lancet 346 1995 1339 1345
21. U. Hobohm Fever and cancer in perspective Cancer Immunol Immunother 50 2001 391 396
22. J.B. Hibbs Jr., L.H. Lambert Jr., and J.S. Remington Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni J Infect Dis 124 1971 587 592
23. M.N. Lunde, and A.H. Gelderman Resistance of AKR mice to lymphoid leukemia associated with a chronic protozoan infection, Besnoitia jellisoni J Natl Cancer Inst 47 1971 485 488
24. J.B. Hibbs Jr., L.H. Lambert Jr., and J.S. Remington Control of carcinogenesis: a possible role for the activated macrophage Science 177 1972 998 1000